By leveraging the expertise of SRx Health’s management team, their pre-existing relationships with pharma, and their robust infrastructure, Better Choice can complement its Halo portfolio of premium ...
The company’s California HMO contract – representing roughly 86% of its Medicare Advantage (MA) membership – has earned an overall 4- out of 5-star rating, marking its eighth consecutive year as a ...
Nelipak Corporation (“Nelipak”), a leading global manufacturer of packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, announced it has ...
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting ...
Princeton, NJ, October 11, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that it has launched a generic paclitaxel formulation in the US, the first generic to ...
At PCF, Auron will present in vitro and in vivo data from AUTX-703, its oral, potent and selective degrader of KAT2A/B that is being developed for the treatment of AML and neuroendocrine carcinomas ...
About Tourmaline Bio Tourmaline is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with ...
DENVER, Oct. 11, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), a leading Program of All-inclusive Care for the Elderly (PACE) provider, plans to highlight its ongoing ...
Sanofi in discussions to sell a controlling stake in Opella. Paris, October 11, 2024. Sanofi today announces that the company has entered into negotiations with CD&R for the poten ...
Realigning resources to focus on clinical advancement of Selected TIL therapy Streamlining operations with cash runway expected to extend into 2Q 2026 SAN DIEGO, Oct. 11, 2024 (GLOBE NEWSWIRE) -- ...
SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced first-in-patient procedures with the ...